Knight Therapeutics Inc. (GUD) Analysts See $0.02 EPS; Profile of 4 Analysts Covering Blueprint Medicines (BPMC) CryptoCoinsTribune
Analysts expect Knight Therapeutics Inc. (TSE:GUD) to report $0.02 EPS on August, 8.They anticipate $0.01 EPS change or 33.33% from last quarter’s $0.03 …